Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF ‑κB signaling pathway.

In conclusion, the present present study demonstrated that CGA improved antitumor immunity, exerting antitumor and anti‑metastatic effects by impairing the NF‑κB/EMT signaling pathway, suggesting that CGA may serve as a potential candidate for therapy of breast cancer. PMID: 33416150 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33416150?dopt=Abstract

Source: Oncology Reports - January 10, 2021 Category: Cancer & Oncology Tags: Oncol Rep Source Type: research